Malignancy incidence after renal transplantation in children: a 20-year single-centre experience.
暂无分享,去创建一个
[1] V. Dharnidharka,et al. Post-transplant lymphoproliferative disease , 2009, Pediatric Nephrology.
[2] M. Moutschen,et al. Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. , 2007, The Journal of infectious diseases.
[3] A. Webster,et al. Identifying High Risk Groups and Quantifying Absolute Risk of Cancer After Kidney Transplantation: A Cohort Study of 15 183 Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] J. Kaldor,et al. Cancer incidence before and after kidney transplantation. , 2006, JAMA.
[5] S. Hariharan,et al. Recommendations for outpatient monitoring of kidney transplant recipients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] C. Jacquelinet,et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] V. Dharnidharka,et al. Risk for post‐transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation , 2005, Pediatric transplantation.
[8] Jean Kanitakis,et al. Skin Cancers Following Pediatric Organ Transplantation , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[9] L. Rees,et al. The post-transplant lymphoproliferative disorder—a literature review , 2004, Pediatric Nephrology.
[10] R. Wolfe,et al. Immunosuppression and the Risk of Post‐Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] L. Swinnen,et al. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation1 , 2003, Transplantation.
[12] H. Sollinger,et al. Long-term outcomes in pediatric renal transplant recipients who survive into adulthood , 2003, Transplantation.
[13] L. Kemény,et al. Skin cancers after organ transplantation. , 2003, The New England journal of medicine.
[14] M. Gruppen,et al. De novo malignancy after paediatric renal replacement therapy , 2001, Archives of disease in childhood.
[15] Michael Green. Management of Epstein–Barr Virus‐induced Post‐transplant Lymphoproliferative Disease in Recipients of Solid Organ Transplantation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] D. Stablein,et al. RISK FACTORS FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN PEDIATRIC KIDNEY TRANSPLANTATION: A REPORT OF THE NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT COOPERATIVE STUDY (NAPRTCS)1 , 2001, Transplantation.
[17] P. Pickhardt,et al. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features. , 2000, Radiology.
[18] B. Kasiske,et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. , 2000, Journal of the American Society of Nephrology : JASN.
[19] T. Srivastava,et al. Posttransplant lymphoproliferative disorder in pediatric renal transplantation , 1999, Pediatric Nephrology.
[20] H. Gritsch,et al. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder. , 1997, Clinical transplantation.
[21] T. Habermann,et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] H. Doornewaard,et al. Posttransplant t‐cell lymphoma. Report of three cases and a review of the literature , 1994, Cancer.
[23] R. Fisher,et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. , 1990, The New England journal of medicine.
[24] John S. Najarian,et al. Pediatric renal transplantation. , 1985, The Surgical clinics of North America.
[25] Christian Jacquelinet,et al. The French Organ Transplant Data System , 2005, MIE.